Find a Tender
complete
Official procurement procedure
Contract for Abatacept (Orencia) (Homecare)
Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Northern Health and Social Care Trust: "Contract for Abatacept (Orencia) (Homecare)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Northern Health and Social Care Trust | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Northern Health and Social Care Trust
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Northern Health and Social Care Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
1Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 17 active published awards; 7 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNorthern Health and Social Care Trust | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published28 Oct 2024, 13:08 GMT | Last source update28 Oct 2024, 13:08 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-04b1d2 | ||
What is being bought
Contract for supply of Abatacept (Orencia) (Homecare) for up to 3 years
What changed
From the official release history
- Status changed to complete
28 Oct 2024, 13:08 GMT - Official notice release published
28 Oct 2024, 13:08 GMT - Buyer information updated
28 Oct 2024, 13:08 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedContract for supply of Abatacept (Orencia) (Homecare) for up to 3 yearsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
28 Oct 2024, 13:08 GMT - Award active
Not published · Not published - Contract active
Signed 1 Oct 2024, 00:00 BST · £1,400,000
Commercial outcome and competition
Awards LLOYDS CLINICAL LIMITED Not published · Not published · active |
Contracts Contract for supply of Abatacept (Orencia) (Homecare) £1,400,000 · signed 1 Oct 2024, 00:00 BST · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Northern Health and Social Care Trust
Contracting authority GB-FTS-34805Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleRegulation 32(2)(b)iii permits the award of a public contract by a negotiated procedure without prior publication where the works, supplies or services can only be supplied by a particular economic operator due to the protection of exclusive rights, including intellectual property rights. The absence of competition is not the result of an artificial narrowing down of the parameters of the procurement.
The NHSCT requires the purchase of Abatacept which is subject to patent protection / Sole MA Holder and consequently no reasonable alternative or substitute exists. |